InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Shah Nikita, Président Exécutif. Insider active across 1 company, notably Amneal Pharmaceuticals, Inc.. Aggregated, 21 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €5.2m. Activity tracked since 15 December 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shah Nikita
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
146,403 股@ US$17.51Class A Common StockSEC:0001628280-26-056757:0
36,232 股Class A Common StockSEC:0001628280-26-015235:0
36,331 股@ US$2.752.8% 占其流量Class A Common StockSEC:0001628280-25-052413:0
114,492 股@ US$9.6631.9% 占其流量Class A Common StockSEC:0001738061-25-000004:0
71,694 股@ US$9.2928.1% 占其流量Class A Common StockSEC:0001723128-25-000052:0
50,000 股@ US$9.0426.5% 占其流量Class A Common StockSEC:0001723128-25-000050:0
49,140 股@ US$7.5830.7% 占其流量Class A Common StockSEC:0001628280-25-026513:0
36,232 股Class A Common StockSEC:0001628280-25-010678:0
28,958 股Class A Common StockSEC:0001628280-25-010113:0
100,000 股@ US$7.7565.0% 占其流量Class A Common StockSEC:0001628280-24-037557:0
28,957 股Class A Common StockSEC:0001628280-24-008945:0
35,620 股Class A Common StockSEC:0001628280-24-007994:0
36,232 股Class A Common StockSEC:0001209191-23-016934:0
18,064 股@ US$1.923.0% 占其流量Class A Common StockSEC:0001209191-23-016934:1
11,729 股Class A Common StockSEC:0001209191-23-015519:0
35,620 股Class A Common StockSEC:0001209191-23-014120:0
4,442 股Class A Common StockSEC:0001209191-22-028163:0
11,728 股Class A Common StockSEC:0001209191-22-016055:0
35,620 股Class A Common StockSEC:0001209191-22-014142:0
2,000 股@ US$3.950.2% 占其流量Class A Common StockSEC:0001209191-21-070257:0
4,441 股Class A Common StockSEC:0001209191-21-031566:0
21 条申报中的 21 条
About Shah Nikita
Shah Nikita is Président Exécutif and Executive Vice President at Amneal Pharmaceuticals, Inc. He has 20 filings in total, and across the 20 sampled filings from 2021-05-11 to 2026-03-05, the reported transactions are exclusively sales, for a total of EUR 2954599, with the dominant transaction nature stated as Levée d'options.
